Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of September, 27 2018
Notification from Donev Investments Holding AD under Art. 19 of Regulation (EU) No 596/2014 of September, 25 and 26 2018
Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of September, 26 2018
Notification for acquisition of own shares
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on 25 September 2018 the Company bought 2 947 own shares representing 0.0022% of the share capital of the Company, at a total value of 12 023.76 BGN on the Bulgarian Stock Exchange, the average price per share was 4.08 BGN.
The trading of treasury shares is pursuant to decision by the Extraordinary General Meeting of Shareholders from 23 February 2018.
The total number of treasury shares after this transaction is 9 113 699, representing 6.76% of the share capital of the Company.
Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of September, 25 2018
Notification from Sopharma AD under Art. 19 of Regulation (EU) No 596/2014 of September, 25 2018
Notification for acquisition of own shares
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on 21 September 2018 the Company bought 3 375 own shares representing 0.0025% of the share capital of the Company, at a total value of 13 770.00 BGN on the Bulgarian Stock Exchange, the average price per share was 4.08 BGN.
The trading of treasury shares is pursuant to decision by the Extraordinary General Meeting of Shareholders from 23 February 2018.